APA Alıntı

Hosogoe, S., Hatakeyama, S., Kusaka, A., Hamano, I., Tanaka, Y., Hagiwara, K., . . . Ohyama, C. (2017). Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma. Oncotarget.

Chicago Stili Alıntı

Hosogoe, Shogo, et al. "Contrast Media Enhancement Reduction Predicts Tumor Response to Presurgical Molecular-targeting Therapy in Patients With Advanced Renal Cell Carcinoma." Oncotarget 2017.

MLA Alıntı

Hosogoe, Shogo, et al. "Contrast Media Enhancement Reduction Predicts Tumor Response to Presurgical Molecular-targeting Therapy in Patients With Advanced Renal Cell Carcinoma." Oncotarget 2017.